Patient‐reported functional and quality‐of‐life outcomes after transanal total mesorectal excision.
Published: 4th February 2019
Authors: D. S. Keller, C. Reali, A. Spinelli, M. Penna, F. Di Candido, C. Cunningham et al.
Impaired function after low anterior resection (LAR) is common and affects quality of life (QoL). Transanal total mesorectal excision (TaTME) may alter functional outcomes but patient‐reported outcomes are scarce. This study assessed functional outcomes and QoL after TaTME for rectal cancer.
Functional outcomes and QoL data from two International Transanal TME Registry centres were reviewed for consecutive patients with rectal cancer undergoing restorative LAR with TaTME. Endpoints were QoL (EuroQol Five Dimensions, European Organisation for Research and Treatment of Cancer QLQ‐C30 and QLQ‐CR29 questionnaires), urogenital function (International Prostate Symptom Score, 5‐item version of International Index of Erectile Function questionnaire and abbreviated McCoy Female Sexuality Function Questionnaire) and bowel function (low anterior resection syndrome (LARS) bowel and Vaizey continence scores) from self‐reported surveys before and 12–24 months after definitive surgery.
Of 61 patients evaluated (82 per cent men), one‐quarter were obese and 44 per cent had neoadjuvant chemoradiotherapy. All tumours were mid‐to‐low rectal, with the anastomosis a mean 3·93 cm from the anal verge. Follow‐up after 12–24 months revealed improved general QoL and emotional function, with preserved urinary, bowel and sexual function. Although 31 per cent reported major LARS, this was comparable to preoperative scores and patients reported good QoL. Regression analysis showed that urinary and bowel functional outcomes did not influence overall QoL; better erectile function was associated with enhanced QoL. Longer transanal operating time was associated with worse LARS.
Follow‐up of at least 1 year after TaTME demonstrated improved QoL and stable or improved functional outcomes.Full text
You may also be interested in
Authors: C. F. Justiniano, Z. Xu, A. Z. Becerra, C. T. Aquina, C. I. Boodry, L. K. Temple et al.
Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer.
Authors: C. Keane, J. Park, S. Öberg, A. Wedin, D. Bock, G. O'Grady et al.
Authors: R. J. Meinds, A. F. W. van der Steeg, C. E. J. Sloots, M. J. Witvliet, I. de Blaauw, W. G. van Gemert et al.
Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer.
Authors: Y. C. Lau, K. Jongerius, C. Wakeman, A. G. Heriot, M. J. Solomon, P. M. Sagar et al.
Cost‐effectiveness analysis of a multicentre randomized clinical trial comparing surgery with conservative management for recurrent and ongoing diverticulitis (DIRECT trial).
Authors: H. E. Bolkenstein, G. A. de Wit, E. C. J. Consten, B. J. M. Van de Wall, I. A. M. J. Broeders, W. A. Draaisma et al.
Notes: Maintained benefits
Authors: L. Koskenvuo, N. Malila, J. Pitkäniemi, J. Miettinen, S. Heikkinen, V. Sallinen et al.
Notes: Only of benefit in men.
Authors: I. van 't Sant, W. J. van Eden, M. P. Engbersen, N. F. M. Kok, K. Woensdregt, D. M. J. Lambregts et al.
Notes: Promising staging tool
Authors: C. T. Aquina, A. Z. Becerra, Z. Xu, C. F. Justiniano, K. Noyes, J. R. T. Monson et al.
Notes: Non‐operative management better
Cost‐effectiveness of liver transplantation in patients with colorectal metastases confined to the liver. BJS 2019; 106: 132-141.
Authors: G. M. W. Bjørnelv, S. Dueland, P.‐D. Line, P. Joranger, Å. A. Fretland, B. Edwin et al.
Notes: Not cost effective for everyone
Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer. BJS 2018; 105: 1553-1572.
Authors: R. Clifford, N. Govindarajah, J. L. Parsons, S. Gollins, N. P. West, D. Vimalachandran et al.
Notes: Promising agents coming
Authors: R. Ahl, P. Matthiessen, X. Fang, Y. Cao, G. Sjolin, R. Lindgren et al.
Notes: Reduces mortality
Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life. BJS 2019; 106: 142-151.
Authors: H. Elfeki, H. M. Larsen, K. J. Emmertsen, P. Christensen, M. Youssef, W. Khafagy et al.
Notes: Substantial impairment common